Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Sep 20, 2024
Artificial Intelligence (AI) is one of the most groundbreaking innovations of the 21st century, with applications spanning nearly every industry, including healthcare. In respiratory care, Artificial intelligence has the potential to enhance accuracy and efficiency while reducing costs. It can play a transformative...
Read More...
Mar 15, 2023
The amount of health and "omics-related data" produced and stored has increased exponentially during the last few decades. In clinical trials, patient data can be gathered in real-time and examined using various artificial intelligence (AI) techniques; mobile devices can also be utilized to enhance certain facets o...
Read More...
Mar 03, 2021
The Covid-19 pandemic has brought unprecedented challenges to the healthcare systems. Not just healthcare; in fact, the whole world came to a standstill. However, technology has played a crucial role in addressing some of the critical issues. The Covid-19 has accelerated the digital transformation and technological...
Read More...
Oct 28, 2020
Artificial intelligence (AI) is the talk of the town. Though the term AI and its uses are not new, however, in the past few years there has been a phenomenal growth in AI research and its applications. Today, AI is making its way in almost every sector. Feeding on a large amount of data, AI can mimic human-like tas...
Read More...
Mar 21, 2019
Biohaven buys PRV from GW Pharmaceuticals for USD 105 million GW Pharmaceuticals has announced its decision to sell its rare pediatric disease priority review voucher (PRV) to Biohaven Pharmaceuticals. The voucher was issued under U.S. Food and Drug Administration programme to accelerate speedy recovery of rare ...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper